Abstract Background and Aim An essential aspect of ensuring availability and stability of
mesenchymal stem/stromal cells (MSCs) products for clinical use is that these cells are …

Cell-based therapy is a promising and innovative new treatment for different degenerative
and autoimmune diseases, and mesenchymal stromal cells (MSCs) from the bone marrow …

Effective cryopreservation strategies for mesenchymal stem cells (MSCs) are highly
essential to be used in future “off-the-shelf” therapeutic purposes. The bone marrow-derived …

Over the past few years, the pace of preclinical stem cell research is astonishing and adult
stem cells have become the subject of intense research. Due to the presence of promising …

Background aims The use of effective methods for the cryopreservation of hematopoietic
stem cells (HSCs) is vital to retain the maximum engraftment activity of cord blood units …

The aim of this study is to investigate the feasibility of using well defined, serum‐free
freezing solutions with a reduced level of dimethylsulfoxide (DMSO) of 7.5, 5, and 2.5%(v/v) …

Introduction The regenerative and immunomodulatory properties of multipotent
mesenchymal stromal cells (MSCs) make them an intriguing asset for therapeutic …

Cryopreservation is the only established method to provide long‐term storage and fast
availability of cellular product for therapeutic applications. The overwhelming majority of …

Mesenchymal stem cells (MSCs) have vast potential in cell therapy, and are experimentally
used in the clinic. Therefore, it is critical to find a serum-and xeno-free cryopreservation …

The advent of stem cells and stem cell-based therapies for specific diseases requires
particular knowledge of laboratory procedures, which not only guarantee the continuous …